Patents by Inventor Scott D. Larsen

Scott D. Larsen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PPAR-SPARING THIAZOLIDINEDIONES AND COMBINATIONS FOR THE TREATMENT OF OBESITY AND OTHER METABOLIC DISEASES
    Publication number: 20120316138
    Abstract: The present invention relates to thiazolidinedione analogues and pharmaceutical compositions that are useful for treating and/or preventing obesity or diabetes, optionally in combination with a second treatment therapy such a diet restriction or an increase in duration or exertion in physical activity.
    Type: Application
    Filed: December 15, 2010
    Publication date: December 13, 2012
    Applicant: METABOLIC SOLUTIONS DEVELOPMENT COMPANY, LLC
    Inventors: Gerard R. Colca, Rolf F. Kletzien, Steven P. Tanis, Scott D. Larsen
  • PPAR-SPARING THIAZOLIDINEDIONE SALTS FOR THE TREATMENT OF METABOLIC DISEASES
    Publication number: 20120309975
    Abstract: The present invention relates to novel salts of thiazolidinediones and other pharmaceutical agents that are useful for treating and/or preventing metabolic diseases (e.g., diabetes, or neurodegenerative diseases (e.g., Alzheimer's Disease).
    Type: Application
    Filed: December 15, 2010
    Publication date: December 6, 2012
    Applicant: Metabolic Solutions Development Company LLC
    Inventors: Gerard R. Colca, Steven P. Tanis, Scott D. Larsen
  • Antiviral agents
    Patent number: 6861438
    Abstract: The invention provides a compound of formula I: wherein G, R2, and R3 have any of the values defined in the specification, or a pharmaceutically acceptable salt thereof, as well as processes and intermediates useful for preparing such compounds or salts, and methods of treating a herpesvirus infection using such compounds or salts.
    Type: Grant
    Filed: January 14, 2003
    Date of Patent: March 1, 2005
    Assignee: Pfizer
    Inventors: Scott D. Larsen, Paul May, Karen Romines, Mark E. Schnute, Steven P. Tanis
  • Antiviral compounds
    Patent number: 6852731
    Abstract: The invention provides a compound of formula I: wherein G, R2, R3, and R4 have any of the values defined in the specification, or a pharmaceutically acceptable salt thereof, as well as processes and intermediates useful for preparing such compounds or salts, and methods of preventing or treating a herpesvirus infection using such compounds or salts.
    Type: Grant
    Filed: January 14, 2003
    Date of Patent: February 8, 2005
    Assignee: Pfizer
    Inventors: Scott D. Larsen, Paul May, Karen Romines, Mark E. Schnute, Steven P. Tanis, James A. Nieman, David John Anderson, Euibong J. Kim, Steven R. Turner
  • ANTIVIRAL COMPOUNDS
    Publication number: 20040242884
    Abstract: The invention provides a compound of formula I: 1
    Type: Application
    Filed: January 14, 2003
    Publication date: December 2, 2004
    Inventors: Scott D. Larsen, Paul May, Karen Romines, Mark E. Schnute, Steven P. Tanis, James A. Nieman, David John Anderson, Euibong J. Kim, Steven R. Turner
  • Heterocycle carboxamides as antiviral agents
    Publication number: 20040180910
    Abstract: The present invention provides a compound of formula I 1
    Type: Application
    Filed: March 29, 2004
    Publication date: September 16, 2004
    Inventors: Mark E. Schnute, Valerie A. Vaillancourt, Scott D. Larsen
  • Heterocycle carboxamides as antiviral agents
    Publication number: 20040142928
    Abstract: The present invention provides a compound of formula I 1
    Type: Application
    Filed: December 23, 2003
    Publication date: July 22, 2004
    Inventors: Gordon L. Bundy, Fred L. Ciske, Michael J. Genin, Steven E. Heasley, Scott D. Larsen, Byung Hyun Lee, Paul D. May, John R. Palmer, Mark E. Schnute, Valerie A. Vaillancourt, Atli Thorarensen, Allison J. Wolf, Nancy Anne Wicnienski, David Wilhite
  • Antiviral agents
    Publication number: 20040138449
    Abstract: The invention provides a compound of formula I: 1
    Type: Application
    Filed: January 14, 2003
    Publication date: July 15, 2004
    Inventors: Scott D. Larsen, Paul May, Karen Romines, Mark E. Schnute, Steven P. Tanis
  • Heterocycle carboxamides as antiviral agents
    Publication number: 20030207880
    Abstract: The present invention provides a compound of formula I 1
    Type: Application
    Filed: December 18, 2002
    Publication date: November 6, 2003
    Inventors: Gordon L. Bundy, Fred L. Ciske, Michael J. Genin, Steven E. Heasley, Scott D. Larsen, Byung Hyun Lee, Paul D. May, John R. Palmer, Mark E. Schnute, Valerie A. Vaillancourt, Atli Thorarensen, Allison J. Wolf, Nancy Anne Wicnienski, David Wilhite
  • 4-oxo-1,4-dihydro-3-cinnolinecarboxamides as antiviral agents
    Patent number: 6624160
    Abstract: This invention provides compounds of formula I; which are useful as antiviral agents.
    Type: Grant
    Filed: March 15, 2001
    Date of Patent: September 23, 2003
    Assignee: Pharmacia & Upjohn Co.
    Inventors: Valerie A. Vaillancourt, Scott D. Larsen, Sajiv K. Nair
  • 4-hydroxycinnoline-3-carboxyamides as antiviral agents
    Patent number: 6458788
    Abstract: Certain novel 4-hydroxycinnoline-3-carboxyamides. The compounds are particularly effective in the treatment or prevention of viral infections, particularly infections caused by herpes viruses including herpes simplex virus types 1 and 2, human herpes virus types 6, 7 and 8, varicello zoster virus, human cytomegalovirus or Epstein-Barr virus.
    Type: Grant
    Filed: March 15, 2001
    Date of Patent: October 1, 2002
    Assignee: Pharmacia & Upjohn Company
    Inventors: Valerie A. Vaillancourt, Scott D. Larsen, Sajiv K. Nair
  • Aminoguanidine carboxylates for the treatment of non-insulin-dependent diabetes mellitus
    Publication number: 20020082448
    Abstract: The present invention provide for a method of reducing blood glucose levels in a patient by administering an effective amount of a compound of the formula III or a pharmaceutically acceptable salt thereof; 1
    Type: Application
    Filed: July 13, 2001
    Publication date: June 27, 2002
    Applicant: The Upjohn Company
    Inventors: Scott D. Larsen, Valerie A. Vaillancourt, Paul D. May, Steven P. Tanis, John A. Tucker, Martin D. Meglasson, Heinrich J. Schostarez
  • Inhibitors of protein tyrosine phosphatase
    Patent number: 6410585
    Abstract: The present invention comprises small molecular weight, non-peptidic inhibitors of formulae I-VII of Protein Tyrosine Phosphatase 1 (PTP1) which are useful for the treatment and/or prevention of Non-Insulin Dependent Diabetes Mellitus (NIDDM).
    Type: Grant
    Filed: March 10, 1999
    Date of Patent: June 25, 2002
    Inventors: Scott D. Larsen, Paul D. May, John E. Bleasdale, Charlotta Liljebris, Heinrich Josef Schostarez, Tjeerd Barf, Marianne Nilsson
  • 4-oxo-1,4-dihydro-3-cinnolinecarboxamides as antiviral agents
    Publication number: 20020045619
    Abstract: This invention provides compounds of formula I; 1
    Type: Application
    Filed: March 15, 2001
    Publication date: April 18, 2002
    Inventors: Valerie A. Vaillancourt, Scott D. Larsen, Sajiv K. Nair
  • 4-hydroxycinnoline-3-carboxyamides as antiviral agents
    Publication number: 20020042397
    Abstract: Certain novel 4-hydroxycinnoline-3-carboxyamides. The compounds are particularly effective in the treatment or prevention of viral infections, particularly infections caused by herpes viruses including herpes simplex virus types 1 and 2, human herpes virus types 6, 7 and 8, varicello zoster virus, human cytomegalovirus or Epstein-Barr virus.
    Type: Application
    Filed: March 15, 2001
    Publication date: April 11, 2002
    Inventors: Valerie A. Vaillancourt, Scott D. Larsen, Sajiv K. Nair
  • Inhibitors of protein tyrosine phosphatase
    Patent number: 6353023
    Abstract: The present invention comprises small molecular weight, non-peptidic inhibitors of formula I and II of Protein Tyrosine Phosphatase 1 (PTP1) which are useful for the treatment and/or prevention of Non-Insulin Dependent Diabetes Mellitus (NIDDM).
    Type: Grant
    Filed: August 24, 1998
    Date of Patent: March 5, 2002
    Assignee: Pharmacia & Upjohn Company
    Inventors: Scott D. Larsen, Paul D. May, John E. Bleasdale, Charlotta Liljebris, Heinrich Josef Schostarez, Tjeerd Barf
  • Heterocycle carboxamides as antiviral agents
    Publication number: 20020025960
    Abstract: The present invention provides a compound of formula I 1
    Type: Application
    Filed: June 22, 2001
    Publication date: February 28, 2002
    Inventors: Gordon L. Bundy, Fred L. Ciske, Michael J. Genin, Steven E. Heasley, Scott D. Larsen, Byung Hyun Lee, Paul D. May, John R. Palmer, Mark E. Schnute, Valerie A. Vaillancourt, Atli Thorarensen, Allison J. Wolf, Nancy Anne Wicnienski, David Wilhite
  • Heterocycle carboxamides as antiviral agents
    Publication number: 20020019397
    Abstract: The present invention provides a compound of formula I 1
    Type: Application
    Filed: June 22, 2001
    Publication date: February 14, 2002
    Applicant: Pharmacia & Upjohn Company
    Inventors: Mark E. Schnute, Valerie A. Vaillancourt, Scott D. Larsen
  • Aminoguanidine carboxylates for the treatment of non-insulin-dependent diabetes mellitus
    Patent number: 6329545
    Abstract: The present invention provides novel compounds of the formula I and II for the treatment of non-insulin dependent diabetes mellitius (NIDDM) and a new use of known compounds for this purpose.
    Type: Grant
    Filed: November 8, 1999
    Date of Patent: December 11, 2001
    Inventors: Scott D. Larsen, Valerie A. Vaillancourt, Paul D. May, Steven P. Tanis, John A. Tucker, Martin D. Meglasson, Heinrich J. Schostarez
  • Aminoguanidine carboxylate lactams for the treatment of non-insulin-dependent diabetes mellitus
    Patent number: 6274580
    Abstract: Compounds selected from the group consisting of formulae I, II, III, IV, VI, VII, and VIII wherein R is H or NH2, and pharmacologically acceptable salts thereof, are suitable for use in methods for treating non-insulin-dependent diabetes mellitus (NIDDM) or obesity in a patient susceptible to or experiencing NIDDM or obesity by the systemic administration of such a compound in an amount effective to treat the NIDDM or obesity.
    Type: Grant
    Filed: August 29, 2000
    Date of Patent: August 14, 2001
    Assignee: Pharmacia & Upjohn Company
    Inventors: Scott D. Larsen, Martin D. Meglasson, Valerie A. Vaillancourt, Paul D. May